Formation Bio
Tech-driven, AI-native pharma company that acquires and develops clinical-stage drugs
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Formation Bio is a tech-driven, AI-native pharmaceutical company that aims to bring new treatments to patients faster by acquiring and developing clinical-stage assets with its own technology platform. Formerly known as TrialSpark, it was co-founded by Benjamine Liu and Linhao Zhang. In October 2026 it announced a $600M Drug Development Accelerator Fund to acquire and advance Phase 1 and Phase 2 drug programs.
- Website
- formation.bio
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageformation.bio
For agents
Nothing listed yet.